Physician Photo

Matthew F. Wszolek, MD

Assistant in Urology, Massachusetts General Hospital

Instructor in Surgery, Harvard Medical School

Matthew F. Wszolek MD is a urologist at the Massachusetts General Hospital Department of Urology. He specializes in the treatment of urologic cancers and related research.

  • Phone: 617-724-7294
Department of Urology


  • Cancer Center
  • Prostate Cancer
  • Testicular Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Genitourinary Oncology
Clinical Interests
Bladder cancer
Prostate cancer
Kidney cancer
Testicular cancer
Ureteral Cancer
Urethral Cancer
Robotic surgery
Boston: Massachusetts General Hospital
Danvers: The Mass General/North Shore Center for Outpatient Care
Medical Education
MD, University of Massachusetts Medical School
Residency, Lahey Clinic
Fellowship, M.D. Anderson Cancer Center
Board Certifications
Urology, American Board of Urology
Patient Gateway
Yes, learn more
Patient Age Group
Accepting New Patients
Accepting New Patients

BiographyDr. Matthew Wszolek is a faculty member of the Department of Urology and a Urologic Oncologist at Massachusetts General Hospital. He finished his urology residency in 2011 and subsequently completed a fellowship in urologic oncology at MD Anderson Cancer Center.  Dr. Wszolek's clinical practice focuses on the surgical treatment of urologic cancers including bladder cancer, prostate cancer, kidney cancer, and testicular cancer through the use of minimally invasive (laparoscopic and robotic) and open techniques.   His research interests include translational research studies in urologic cancers with a focus on bladder cancer. 


View my most recent publications at PubMed

Culp SH, Dickstein RJ, Grossman HB, Pretzsch SM, Porten S, Daneshmand S, Cai J, Groshen S, Siefker-Radtke A, Millikan RE, Czerniak B, Navai N, Wszolek MF, Kamat AM, Dinney CP, Refining Patient Selection for Neoadjuvant Chemotherapy Prior to Radical Cystectomy, J Urol, 2013 Jul 30, [Epub ahead of print]

Dinney CP, Fisher MB, Navai N, ODonnell MA, Cutler D, Abraham A, Young S, Hutchins B, Grossman HB, Kamat A, Gonzales M, Ainslee N, Wszolek MF, Benedict WF, Phase I Trial of Intravesicle Recombinant Adenovirus-Mediated Interferon Alpha Formulated in Syn3 for BCG-resistant Non-Muscle Invasive Bladder Cancer, J Urol, 2013 Mar 15 [Epub ahead of print]

Adam L, Wszolek MF, Chang-Gong L, Wang J, Diao L, Zien A, Zhang JD, Jackson D, Dinney CP, Plasma MicroRNA Profiles for Bladder Cancer Detection, Urologic Oncology, 2012, Aug 2 [Epub ahead of print]

Wszolek MF, Rieger-Christ K, Kenney PA, Gould JJ, Neto BS, LaVoie AK, Logvinenko T, Libertino JA, Summerhayes IC, A microRNA Expression Profile Defining the Invasive Bladder Tumor Phenotype, Urologic Oncology: Seminars and Original Investigations, 2011, 29(6): 794-801.

Wszolek MF, Kenney PA, Lee Y, Libertino JA, Comparison of Hilar Clamping and Non-Hilar Clamping Partial Nephrectomy for Tumors Involving a Solitary Kidney, BJU Int, 2011; 107 (12): 1886-92.

Department of Urology
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-724-7294

Mass General/North Shore Center for Outpatient Care
104 Endicott Street
Danvers, MA 01923-3623

Phone: 978-882-6800